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LOWER DOSE OF INTRAVENOUS IMMUNOGLOBULIN (I.V.IG) RESULTS IN
COMPARABLE OUTCOME IN CHILDREN WITH NEWLY DIAGNOSED ITP
Vineetha Raghavan, Chandran K. Nair, Anju R. Kurup. Malabar Cancer
Centre, Thalassery, India
Background: I.V.IG has been shown to be effective in Immune Thrombo-
cytopenia since 1981. The recommended dose is 0.4 g/kg/day for 5 days or
0.8 - 1 g/kg/day for 2 days. ASH 2011 guidelines say that a single dose of 0.8
- 1 g/kg of I.V.IG is also effective. But it has not become the standard of care
in all centres in India. At our centre we give single dose of 0.8- 1 g/kg
(capped off as per body weight) of I.V.IG to newly diagnosed acute ITP
patients who can afford the drug, and then check the response 48 hours
after the infusion. A second dose is administered only if there is no satis-
factory response with the ﬁrst dose. This mode of treatment helps in
reducing the cost of treatment and also the side effects of IVIG. With this
backgroundwe tried to assess the response to lower single dose of I.V.IG in
children with newly diagnosed ITP treated at MCC.
Method:Reviewofcasesheetsof6childrenwithnewlydiagnosed ITP treated
with I.V IG. For each patient, Baseline characteristics like Platelet count prior
to I.V.IG therapy, Presence of skin bleeds, Presence of mucosal bleeds were
noted. Immediate responsewasmeasuredbymeasuring theplatelet count48
hours after I.V.IG infusion. Response criteriawere chosen as per International
working group recommendations (Rodeghiero F et al, Blood 2009)
Result: 6 case ﬁles were reviewed. There were 2 girls and 4 boys. Out of
these six children who received single dose of 0.8 to 1 g/kg I.V.IG, half
required a second dose 48 hours later. Response to I.V.IG in these children
were as represented in table 1.Table 1
Case 1 Case 2 Case 3 Case 4 Case 5 Case 6
Age/Sex 3 year/Male 5.5 years/Male 11 years/Male 3 years/Female 4.5 years/Male 10 years /Female
Baseline Platelet count (/mm3) 6000 14000 4000 9000 10000 10000
Skin bleeds at presentation (Yes/No) Yes Yes Yes Yes Yes Yes
Mucosal bleeds at presentation (Yes/No) Yes Yes No Yes No No
Duration of symptoms (days) 3 4 7 7 4 45
Platelet count 48 hours later (/mm3) 25000 83000 12000 21000 20000 44000
Resolution of bleeding symptoms at 48 hours Yes Yes Yes Yes Yes Yes
Second dose Required 48 hours after
ﬁrst dose (Yes/No)
No No Yes Yes Yes No
Platelet count 48 hours after second
dose of IVIG (/mm3)
NA NA 94000 31000 35000 NA
Quality of response CR CR R CR R R
Time to response (days) 261 8 4 46 4 1
Duration of follow up (days) 618 458 403 185 135 6
Duration of response (days) Still in CR Still in CR 11 Still in CR 12 Still in R
Side effects of I.V.IG therapy Fever, Shivering Fever None Fever None None“Complete response” (CR) is deﬁned as any platelet count of at least 100 
109/L. “Response” (R) is deﬁned as any platelet count between 30 and 100
 109/L and at least doubling of the baseline count. “No response” (NR) is
deﬁned as any platelet count lower than 30 109/L or less than doubling of
the baseline count.“Duration of the response” is calculated from the time of CR or R until loss
of CR or R.
Conclusion: Lower doses of IVIG is a cheaper but effective treatment op-
tion in children with newly diagnosed ITP in resource limited settings. We
could show that, if administered for one day alone the cost can be cut
down to half. Only those patients who do not respond to one dose need to
be administered a second dose.
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TO STUDY THE FACTORS AFFECTING QUALITY OF LIFE IN CHILDREN
SUFFERING FROM HEMOPHILIA
Mohammad Salmaan, Mamta Manglani, Maninder Sethia, Sujata
Sharma, R. Nikila, Sonia Karapurkar. Department of Pediatrics, Division of
Pediatric Hematology-Oncology, Lokmanya Tilak Municipal Medical College
and General Hospital, Sion, Mumbai, India
Background: Hemophilia is the most common severe bleeding disorder in
the world caused due to a single gene mutation. India has the second
largest number of Hemophilia patients in the world. Being a chronic dis-
ease, hemophilia has signiﬁcant impact on the quality of life which needs
to be assessed. This study was designed to assess the qol in children with
hemophilia and identify the factors that predict their qol, in order to better
plan and distribute the health care resources.
Material and Methods: This was a cross-sectional case control study
which included 30 children suffering from Hemophilia as cases and 30
normal healthy siblings' as controls aged between 5-12 years. The quality
of life assessment was performed using the Pediatric Quality of Life In-
ventory (PedsQoL) 4.0 Generic Core Scale. Two separate questionnaires
were administered for children between age group of 5 to 7 years and 8 to12 years. For the purpose of analysis Joint, Muscle and Intracranial bleeds
were together classiﬁed as Major bleeds, whereas skin and mucosal bleeds
as Minor bleeds. Data was analyzed using Stata Version 13. The means
between two groups were compared using the unpaired and paired t-test
(for different groups, and pre-and post-means respectively and Analysis of
Abstracts / Pediatric Hematology Oncology Journal 1 (2016) S1eS33S2Variance (ANOVA) for comparison of means across more than two groups.
The proportions were compared using the chi square test or the Fisher's
exact test (for low expected cell counts).
Results: The mean age of the study group was 8.08 years, while that of the
control group was 8.88 years. Eighty percent had Hemophilia A and 20%
had Hemophilia B. Severe hemophilia was seen in 87% and 13% had
moderate Hemophilia. Themean scores of the child self-report and parent
proxy report (results of the questionnaire answered by the parent) of the
study group was 79.81 and 72.75 respectively, which was signiﬁcantly
lower as compared to the control group, suggestive of impaired quality of
life .The mean scores of the parent proxy report were signiﬁcantly lower
than the child report scores for both the study and control groups, indi-
cating parents reporting of impaired quality of life of the affected chil-
dren. Joint bleeds were present in 36.66%, 73.3% had muscle bleeds and
16.66% had intracranial bleeds. Target joints were present in 13.33%. The
median number of hospitalizations was 3 from date of diagnosis till the
inclusion of the patients in the study group. The quality of life was
signiﬁcantly affected in children with more number of bleeding episodes
and with the presence of target joints. The qol was not signiﬁcantly
affected by the age of diagnosis, duration of illness and the socioeconomic
status.
Conclusion: The Quality of Life of children with Hemophilia is signiﬁ-
cantly impaired as compared to the general population. Number of Hos-
pitalizations, presence of target joints, number of bleeding episodes, age
at diagnosis and duration of disease were associated with the quality of
life of children with hemophilia and hence rehabilitation measures
should be encouraged along with primary factor prophylaxis and
encouraging the patients to learn home treatment to improve scores and
quality of life.
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GLANZMANN'S THROMBASTHENIA e CLINICAL PROFILE OF PATIENTS
IN A TERTIARY CARE CENTRE IN SOUTH INDIA
K. Smitha 1, M. Jyothi 1, D. Tarangini 1, Anand Prakash 1, Fulton D.
Souza 1, Sitalakshmi Subramanian 2. 1Department of Paediatrics, Unit of
Hematology e Oncology, India; 2Department of Transfusion Medicine and
Immunohematology, St John's Medical College Hospital, Bangalore, India
Abstract
Objectives: To describe the clinical proﬁle of Glanzmann's Thrombasthe-
nia (GT) in a tertiary care centre in South India.
Methods: Retrospective descriptive study done by chart review of all pa-
tients on follow up between Jan 2005 e Aug 2016. Study population
included all children less than 18 years of age diagnosed at our centre. A
diagnosis of GT was made based on standard criteria.
Results: A total of 46 patients (representing 42 families) are being
described in this study. Mean age at presentation was 4 years. 65.2% (30/
46) had ﬁrst bleed within the ﬁrst two years of life. The male to female
ratio was 1.4:1. 21/46 children (46%) were born out of consanguineous
marriage. The common symptoms were epistaxis, gingival bleeding and
skin bleeds. Gastrointestinal bleeding in the form of hematemesis and
melena was frequent, hemarthrosis and intracranial bleed was rarely seen
while muscle involvement and hemoptysis was not seen. Post surgical
bleed in the form of tonsillar bleed following tonsillectomy was common.
Presentation in the neonatal period was rare (<1%) and was observed in
the form of purpura, epistaxis and intracranial bleed. Menorrhagia was the
most common presentation in children ﬁrst presenting in teenage. 25%
had life threatening bleeds while 50% had growth retardation due to
chronic anemia.
Conclusion: Knowledge of the clinical proﬁle of this disease will aid in
suspecting and promptly evaluating the disease as early diagnosis aids in
preventing life threatening bleeds.
BDT-1_V1.4
RARE PRESENTATION OF A RARE BLEEDING DISORDER
Vinay Kumar 1, G. Sushil 1, D. Tarangini 1, A. Shashidhar 2, Anand
Prakash 1. 1Department of Pediatrics, Unit of Hematology e Oncology, St
John's Medical College Hospital, Bangalore, India; 2Department of
Neonatology, St John's Medical College Hospital, Bangalore, IndiaBackground: Factor V deﬁciency (Parahemophilia) is a rare autosomal
recessive bleeding disorder with an incidence of 1 in million persons. The
most common bleeding symptoms are mucocutaneous bleeds, menor-
rhagia and post surgical bleeds. There are anecdotal case reports of life
threatening bleeds in severe Factor V deﬁciency. We present two young
infants with prolonged PT/aPTT with this rare bleeding disorder causing
Intra cranial hemorrhage.
Methods: We report two children with severe Factor V deﬁciency with
severe unusual bleed presented to St John's Medical College Hospital,
Bengaluru.
Case 1: A 3 months old baby boy with uneventful perinatal period pre-
sented with complaints of seizures. He was in altered sensorium with
severe pallor, bulging anterior fontanel, unequal pupils and exaggerated
DTR. Initial blood investigations revealed severe anemia, prolonged PT (70
sec), aPTT (120 sec), INR (9) and normal TT (13.7 sec). Neuroimaging (CT
Brain) showed left intra-cerebral bleed extending from the frontal lobe to
the parieto-occipital region with 5mm shift of the midline to the right. A
possibility of Late onset VKDB or Common pathway deﬁciency was
considered in view of no improvement in PT/aPTT with Inj Vit K and FFP.
Factor assay were sent which showed Factor V levels of <1%.
Case 2: A 4 day old baby girl was referred to our institute with complaints
of bleeding from nose and umbilical stump. Child had received Inj Vit K at
birth. On examination the child was active, alert with few ecchymotic
patches over the limbs and cephalhaematoma. Initial blood tests revealed
anemia, prolonged PT (30 sec), aPTT (78 sec), normal TT. Child was
managed with PRBC transfusion, Inj Vit K and other supportive measures.
On the same day she developed massive intra cranial hemorrhage leading
uncal herniation and succumbed.
Conclusion: Considering bleeding disorder other than VKDB in neonates
and young infants with prolonged PT/aPTT is important in diagnosis of rare
bleeding disorder with life threatening complications.
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PROFILE OF THROMBOCYTOPENIA IN INPATIENT CHILDREN WITH
ACUTE FEBRILE ILLNESS IN A TERTIARY CARE CENTRE
Sharan Subramanian 1, Surbhi Rathi 1, Santosh Kondekar 1, Purvi
Kadakia 2. 1Department of Pediatrics, TNMC & BYL Nair Charitable
Hospital, India; 2Department of Medical Oncology, TNMC & BYL Nair
Charitable Hospital, India
E-mail address: doctorsharan@gmail.com (S. Subramanian).
Background: Acute febrile illness with thrombocytopenia is a common
problem with increased mortality and morbidity if not diagnosed and
treated promptly. There is a need to ascertain the prevalence and causes of
febrile thrombocytopenia to enable monitoring and prompt treatment.
Objectives: To estimate the prevalence and identify the underlying etiol-
ogy of thrombocytopenia in children presenting with acute febrile illness,
and to determine the need for platelet transfusion.
Materials and Methods: 192 inpatient children in the age group of 3
months to 12 years presenting with fever of 1-14 days duration over a
period of 3 months were included in the study. The discharge cards of the
recruited subjects were reviewed. Platelet counts at admission and during
hospital stay were noted. Platelet transfusions, when given, were docu-
mented. The etiological proﬁle of the fever was assessed to evaluate the
causes of thrombocytopenia. Chisquare test was used to test the associa-
tion between thrombocytopenia and its different causes. p value <0.05
was taken as statistically signiﬁcant.
Results: The hospital based prevalence of thrombocytopenia in acute febrile
illness in our centre was 22.9% (n¼192). The most common cause of
thrombocytopenia was Dengue fever (38.6%) followed by Acute Febrile
Illness of unknown etiology (29.5%). Other causes included Leptospirosis
(6.8%),Malaria (9.2%), Pneumonia (9.2%), Bronchiolitis (4.5%) andUTI (2.2%). 9
out of 26 cases of Dengue fever were not associatedwith thrombocytopenia.
On statistical analysis, there was a signiﬁcant association between throm-
bocytopenia and Dengue fever (p<0.01) over the other causes of fever. The
mean duration after onset of fever at which thrombocytopeniawas detected
was found to be Day 7. Platelet transfusion was required only in 1 patient in
view of hematemesis and malena at a platelet count of 34,000/cu.mm.
Conclusions: Febrile thrombocytopenia is a common clinical condition
requiring detection and monitoring. Infections, particularly Dengue, were
